|Bid||32.08 x 1000|
|Ask||32.13 x 800|
|Day's Range||29.80 - 32.14|
|52 Week Range||20.71 - 76.81|
|Beta (5Y Monthly)||1.20|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 10, 2022 - Aug 15, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||64.38|
Subscribe to Yahoo Finance Plus to view Fair Value for SDGR
NEW YORK, June 28, 2022--Schrödinger today announced FDA clearance of investigational new drug application for SGR-1505, a MALT1 inhibitor.
With the business potentially at an important milestone, we thought we'd take a closer look at Schrödinger, Inc.'s...
NEW YORK, June 22, 2022--Schrödinger convenes global educators for second annual Educator’s Day.